| abstract |
The compounds of formula I, and pharmaceutically acceptable salts thereof, are useful for the parenteral treatment of leukemia, myelodysplastic syndrome or lymphoma, particularly in patients with cytarabine resistance and/or in patients over 60 years of age. Formula I In Formula I, X is a bond or -CH 2 . |